ArticleCancers2020

Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma.

Nagjie Alijaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.